Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF

CBE ID

0070e

Endorsement Status

Endorsed

1.0 New or Maintenance

Maintenance

1.1 Measure Structure

Single Measure

Previous Endorsement Cycle

Spring 2019

Is Under Review

Next Maintenance Cycle

Spring 2026

1.6 Measure Description

Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF <40% who were prescribed beta-blocker therapy

Measure Specs

General Information

1.7 Measure Type

Process

1.3 Electronic Clinical Quality Measure (eCQM)

Yes

1.8 Level of Analysis

Clinician: Group/Practice

Clinician: Individual

1.9 Care Setting

Other

Numerator

1.14 Numerator

Patients who were prescribed beta-blocker therapy

Denominator

1.15 Denominator

All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior (within the past 3 years) MI or a current or prior LVEF <40%

Exclusions

Denominator Exceptions:
Documentation of medical reason(s) for not prescribing beta-blocker therapy (e.g., allergy, intolerance, other medical reasons).

Documentation of patient reason(s) for not prescribing beta-blocker therapy (e.g., patient declined, other patient reasons).

Documentation of system reason(s) for not prescribing beta-blocker therapy (e.g., other reasons attributable to the health care system).

Measure Record

Most Recent Endorsement Activity

Endorsed Cardiovascular Spring Cycle 2019

Initial Endorsement

2016-12